BACKGROUND: Autologous bone grafts remain a standard of care for the reconstruction of large bony defects, but limitations persist. The authors explored the bone regenerative capacity of customized, three-dimensionally printed bioactive ceramic scaffolds with dipyridamole, an adenosine A2A receptor indirect agonist known to enhance bone formation. METHODS: Critical-size bony defects (10-mm height, 10-mm length, full-thickness) were created at the mandibular rami of rabbits (n = 15). Defects were replaced by a custom-to-defect, three-dimensionally printed bioactive ceramic scaffold composed of β-tricalcium phosphate. Scaffolds were uncoated (control), collagen-coated, or immersed in 100 μM dipyridamole. At 8 weeks, animals were euthanized and the rami retrieved. Bone growth was assessed exclusively within scaffold pores, and evaluated by micro-computed tomography/advanced reconstruction software. Micro-computed tomographic quantification was calculated. Nondecalcified histology was performed. A general linear mixed model was performed to compare group means and 95 percent confidence intervals. RESULTS: Qualitative analysis did not show an inflammatory response. The control and collagen groups (12.3 ± 8.3 percent and 6.9 ± 8.3 percent bone occupancy of free space, respectively) had less bone growth, whereas the most bone growth was in the dipyridamole group (26.9 ± 10.7 percent); the difference was statistically significant (dipyridamole versus control, p < 0.03; dipyridamole versus collagen, p < 0.01 ). There was significantly more residual scaffold material for the collagen group relative to the dipyridamole group (p < 0.015), whereas the control group presented intermediate values (nonsignificant relative to both collagen and dipyridamole). Highly cellular and vascularized intramembranous-like bone healing was observed in all groups. CONCLUSION: Dipyridamole significantly increased the three-dimensionally printed bioactive ceramic scaffold's ability to regenerate bone in a thin bone defect environment.
BACKGROUND: Autologous bone grafts remain a standard of care for the reconstruction of large bony defects, but limitations persist. The authors explored the bone regenerative capacity of customized, three-dimensionally printed bioactive ceramic scaffolds with dipyridamole, an adenosine A2A receptor indirect agonist known to enhance bone formation. METHODS: Critical-size bony defects (10-mm height, 10-mm length, full-thickness) were created at the mandibular rami of rabbits (n = 15). Defects were replaced by a custom-to-defect, three-dimensionally printed bioactive ceramic scaffold composed of β-tricalcium phosphate. Scaffolds were uncoated (control), collagen-coated, or immersed in 100 μM dipyridamole. At 8 weeks, animals were euthanized and the rami retrieved. Bone growth was assessed exclusively within scaffold pores, and evaluated by micro-computed tomography/advanced reconstruction software. Micro-computed tomographic quantification was calculated. Nondecalcified histology was performed. A general linear mixed model was performed to compare group means and 95 percent confidence intervals. RESULTS: Qualitative analysis did not show an inflammatory response. The control and collagen groups (12.3 ± 8.3 percent and 6.9 ± 8.3 percent bone occupancy of free space, respectively) had less bone growth, whereas the most bone growth was in the dipyridamole group (26.9 ± 10.7 percent); the difference was statistically significant (dipyridamole versus control, p < 0.03; dipyridamole versus collagen, p < 0.01 ). There was significantly more residual scaffold material for the collagen group relative to the dipyridamole group (p < 0.015), whereas the control group presented intermediate values (nonsignificant relative to both collagen and dipyridamole). Highly cellular and vascularized intramembranous-like bone healing was observed in all groups. CONCLUSION:Dipyridamole significantly increased the three-dimensionally printed bioactive ceramic scaffold's ability to regenerate bone in a thin bone defect environment.
Authors: Firas M Kara; Stephen B Doty; Adele Boskey; Steven Goldring; Mone Zaidi; Bertil B Fredholm; Bruce N Cronstein Journal: Arthritis Rheum Date: 2010-02
Authors: Sarita R Shah; Simon Young; Julia L Goldman; John A Jansen; Mark E Wong; Antonios G Mikos Journal: Nat Protoc Date: 2016-09-22 Impact factor: 13.491
Authors: Falk Wehrhan; Kerstin Amann; Aart Molenberg; Rainer Lutz; Friedrich W Neukam; Karl A Schlegel Journal: Clin Oral Implants Res Date: 2011-12-12 Impact factor: 5.977
Authors: Johan van der Stok; Huanan Wang; Saber Amin Yavari; Michiel Siebelt; Marjan Sandker; Jan H Waarsing; Jan A N Verhaar; Holger Jahr; Amir A Zadpoor; Sander C G Leeuwenburgh; Harrie Weinans Journal: Tissue Eng Part A Date: 2013-08-17 Impact factor: 3.845
Authors: Jason A Inzana; Diana Olvera; Seth M Fuller; James P Kelly; Olivia A Graeve; Edward M Schwarz; Stephen L Kates; Hani A Awad Journal: Biomaterials Date: 2014-02-14 Impact factor: 12.479
Authors: Alexander S Spiro; F Timo Beil; Anke Baranowsky; Florian Barvencik; Arndt F Schilling; Khoa Nguyen; Shahram Khadem; Sebastian Seitz; Johannes M Rueger; Thorsten Schinke; Michael Amling Journal: J Orthop Res Date: 2010-06 Impact factor: 3.494
Authors: Christopher D Lopez; Paulo G Coelho; Lukasz Witek; Andrea Torroni; Michael I Greenberg; Dean L Cuadrado; Audrey M Guarino; Jonathan M Bekisz; Bruce N Cronstein; Roberto L Flores Journal: Plast Reconstr Surg Date: 2019-08 Impact factor: 4.730
Authors: Maxime M Wang; Roberto L Flores; Lukasz Witek; Andrea Torroni; Amel Ibrahim; Zhong Wang; Hannah A Liss; Bruce N Cronstein; Christopher D Lopez; Samantha G Maliha; Paulo G Coelho Journal: Sci Rep Date: 2019-12-05 Impact factor: 4.379
Authors: J Girón; E Kerstner; T Medeiros; L Oliveira; G M Machado; C F Malfatti; P Pranke Journal: Braz J Med Biol Res Date: 2021-06-14 Impact factor: 2.590